Apg Asset Management N.V. Lantheus Holdings, Inc. Transaction History

Apg Asset Management N.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$51.07 - $68.26 $3.54 Million - $4.74 Million	69,400 Added 598.28%	81,000 $5.04 Million
Q4 2023 Feb 13, 2024	BUY	$55.6 - $77.89 $644,960 - $903,524	11,600 New	11,600 $719,000
Q1 2020 May 14, 2020	SELL	$9.11 - $20.05 $2.01 Million - $4.42 Million	-220,364 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$18.47 - $24.03 $565,182 - $735,318	30,600 Added 16.13%	220,364 $4.03 Million
Q3 2019 Nov 08, 2019	BUY	$21.01 - $28.94 $3.99 Million - $5.49 Million	189,764 New	189,764 $4.36 Million

533

73.2M

598K

371K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.03B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.